Cargando…
Chronic and delayed neurological manifestations of persistent infections
Persistent infections capable of causing central nervous system (CNS) complications months or years after the initial infection represent a major public health concern. This concern is particularly relevant considering the ongoing coronavirus disease 2019 pandemic, where the long-term neurological e...
Autores principales: | , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Lippincott Williams & Wilkins
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10155704/ https://www.ncbi.nlm.nih.gov/pubmed/37078647 http://dx.doi.org/10.1097/WCO.0000000000001154 |
_version_ | 1785036387609739264 |
---|---|
author | Pandya, Darshan Johnson, Tory P. |
author_facet | Pandya, Darshan Johnson, Tory P. |
author_sort | Pandya, Darshan |
collection | PubMed |
description | Persistent infections capable of causing central nervous system (CNS) complications months or years after the initial infection represent a major public health concern. This concern is particularly relevant considering the ongoing coronavirus disease 2019 pandemic, where the long-term neurological effects are still being recognized. RECENT FINDINGS: Viral infections are a risk factor for the development of neurodegenerative diseases. In this paper, we provide an in-depth exploration of the prevalent known and suspected persistent pathogens and their epidemiological and mechanistic links to later development of CNS disease. We examine the pathogenic mechanisms involved, including direct viral damage and indirect immune dysregulation, while also addressing the challenges associated with detecting persistent pathogens. SUMMARY: Viral encephalitis has been closely associated with the later development of neurodegenerative diseases and persistent viral infections of the CNS can result in severe and debilitating symptoms. Further, persistent infections may result in the development of autoreactive lymphocytes and autoimmune mediated tissue damage. Diagnosis of persistent viral infections of the CNS remains challenging and treatment options are limited. The development of additional testing modalities as well as novel antiviral agents and vaccines against these persistent infections remains a crucial research goal. |
format | Online Article Text |
id | pubmed-10155704 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2023 |
publisher | Lippincott Williams & Wilkins |
record_format | MEDLINE/PubMed |
spelling | pubmed-101557042023-05-04 Chronic and delayed neurological manifestations of persistent infections Pandya, Darshan Johnson, Tory P. Curr Opin Neurol CNS INFLAMMATORY DISORDERS: INFECTIOUS DISEASES: Edited by Bruce T. Volpe Persistent infections capable of causing central nervous system (CNS) complications months or years after the initial infection represent a major public health concern. This concern is particularly relevant considering the ongoing coronavirus disease 2019 pandemic, where the long-term neurological effects are still being recognized. RECENT FINDINGS: Viral infections are a risk factor for the development of neurodegenerative diseases. In this paper, we provide an in-depth exploration of the prevalent known and suspected persistent pathogens and their epidemiological and mechanistic links to later development of CNS disease. We examine the pathogenic mechanisms involved, including direct viral damage and indirect immune dysregulation, while also addressing the challenges associated with detecting persistent pathogens. SUMMARY: Viral encephalitis has been closely associated with the later development of neurodegenerative diseases and persistent viral infections of the CNS can result in severe and debilitating symptoms. Further, persistent infections may result in the development of autoreactive lymphocytes and autoimmune mediated tissue damage. Diagnosis of persistent viral infections of the CNS remains challenging and treatment options are limited. The development of additional testing modalities as well as novel antiviral agents and vaccines against these persistent infections remains a crucial research goal. Lippincott Williams & Wilkins 2023-06 2023-04-19 /pmc/articles/PMC10155704/ /pubmed/37078647 http://dx.doi.org/10.1097/WCO.0000000000001154 Text en Written work prepared by employees of the Federal Government as part of their official duties is, under the U.S. Copyright Act, a “work of the United States Government” for which copyright protection under Title 17 of the United States Code is not available. As such, copyright does not extend to the contributions of employees of the Federal Government. |
spellingShingle | CNS INFLAMMATORY DISORDERS: INFECTIOUS DISEASES: Edited by Bruce T. Volpe Pandya, Darshan Johnson, Tory P. Chronic and delayed neurological manifestations of persistent infections |
title | Chronic and delayed neurological manifestations of persistent infections |
title_full | Chronic and delayed neurological manifestations of persistent infections |
title_fullStr | Chronic and delayed neurological manifestations of persistent infections |
title_full_unstemmed | Chronic and delayed neurological manifestations of persistent infections |
title_short | Chronic and delayed neurological manifestations of persistent infections |
title_sort | chronic and delayed neurological manifestations of persistent infections |
topic | CNS INFLAMMATORY DISORDERS: INFECTIOUS DISEASES: Edited by Bruce T. Volpe |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10155704/ https://www.ncbi.nlm.nih.gov/pubmed/37078647 http://dx.doi.org/10.1097/WCO.0000000000001154 |
work_keys_str_mv | AT pandyadarshan chronicanddelayedneurologicalmanifestationsofpersistentinfections AT johnsontoryp chronicanddelayedneurologicalmanifestationsofpersistentinfections |